Warrants (Details) - $ / shares |
3 Months Ended | ||
|---|---|---|---|
Nov. 19, 2025 |
Jul. 13, 2025 |
Mar. 31, 2026 |
|
| Warrants [Line Items] | |||
| Sales price of per share | $ 18 | ||
| Trading day period commencing threshold | 20 days | ||
| Trading day period commencing once ending day | 30 days | ||
| Warrants [Member] | |||
| Warrants [Line Items] | |||
| Exercise price | $ 2.5 | $ 5 | $ 0.01 |
| Days Completion Of The Reverse Recapitalization | 30 years | ||
| Issued private placement warrants | 250,000 | 100,000 | |
| Purchase common shares | 250,000 | 100,000 |
| X | ||||||||||
- Definition Days completion of the reverse recapitalization. No definition available.
|
| X | ||||||||||
- Definition Number of common shares purchase. No definition available.
|
| X | ||||||||||
- Definition Number of issued private placement warrants. No definition available.
|
| X | ||||||||||
- Definition Trading day period commencing once ending days. No definition available.
|
| X | ||||||||||
- Definition Trading day period commencing threshold. No definition available.
|
| X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction. No definition available.
|
| X | ||||||||||
- Details
|